BA closed Tuesday at $187.68, up 1.8% on the day but still down 5% on the week and more than 10% over the past month, leaving the stock nearly $85 below the Street's mean price target of $273.
Options positioning has shifted notably more bullish since the Jefferies cut last week. The put/call ratio fell to 0.82 on Tuesday, more than two standard deviations below its 20-day average of 0.88, its lowest reading in over a year against a 52-week low of 0.72. That is a meaningful tilt toward calls rather than puts, and it runs in the opposite direction from the stock's price action. Short positioning offers no amplifying pressure on either side. Short interest is a modest 1.9% of free float, down 13% on the week after a sharp drop around September 23. The borrow market is completely loose: cost to borrow fell 42% on the week to just 0.20%, and availability is running at roughly 6,490% of shares short. For every share currently borrowed, the lending pool holds around 65 more. The short score has drifted gently lower all week, settling at 31.4. There is no short-side tension here.
The analyst picture has become the primary story, and the tension within it has sharpened since last week's note. The consensus remains firmly bullish: zero Sell ratings, a mean target near $273, implying roughly 45% upside from Tuesday's close. But the gap between that target and the traded price now looks less like optimism and more like a credibility discount. The most recent move came from Jefferies, which cut its target from $295 to $265 last week while holding its Buy, a trim that signals eroding conviction without surrendering the thesis. BofA reiterated its Buy at $270 a day earlier. The bull case is concrete: a $715 billion backlog, twelve-month revenue up nearly 25% year on year to $93.99 billion, and operating cash flow turning from a $3.52 billion loss to a $1.34 billion gain. The bear case is equally concrete: every one of those improvements depends on management hitting production targets while navigating regulatory scrutiny, program delays, and a defense portfolio under execution pressure. EPS momentum scores in the 98th percentile, and the company has beaten estimates at a 93rd-percentile rate, so the fundamental trajectory is real. The market simply does not yet trust the pace.
Institutional ownership is stable and concentrated. BlackRock holds 7.7% as of late September, Vanguard Capital Management 7.1%, and FMR LLC 6.3%, all with small recent additions. Capital Research and Management added nearly 10 million shares in the most recent reported period, a notable build to 5.1% of shares. No 13D activist is on the register. The 13G filings from the major holders carry the standard caveat: stakes are as last disclosed around the 5% threshold, and a holder dropping below that level may not file again. Insider activity in the 90-day window is dominated by tax-withholding transactions, which are compensation mechanics rather than discretionary signals. The one genuine open-market purchase in the window came from director Bradley Tilden in May, 1,370 shares at $218.50, well above where the stock now trades.
Earnings fall on October 21. The last print on July 29 saw the stock essentially flat on the day but up 8.4% over the following five sessions. The print before that produced a similar pattern: a muted one-day reaction followed by a meaningful multi-day move. The setup heading into this quarter's release is therefore less about whether Boeing's recovery is real and more about whether the company can close the gap between the trajectory its financials describe and the execution risk the market continues to price in at $187.
See the live data behind this article on ORTEX.
Open BA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
